279 related articles for article (PubMed ID: 28356344)
1. YAP promotes myogenic differentiation
Chen TH; Chen CY; Wen HC; Chang CC; Wang HD; Chuu CP; Chang CH
FASEB J; 2017 Jul; 31(7):2963-2972. PubMed ID: 28356344
[TBL] [Abstract][Full Text] [Related]
2. MEK5 and ERK5 are mediators of the pro-myogenic actions of IGF-2.
Carter EJ; Cosgrove RA; Gonzalez I; Eisemann JH; Lovett FA; Cobb LJ; Pell JM
J Cell Sci; 2009 Sep; 122(Pt 17):3104-12. PubMed ID: 19654213
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitin-dependent regulation of MEKK2/3-MEK5-ERK5 signaling module by XIAP and cIAP1.
Takeda AN; Oberoi-Khanuja TK; Glatz G; Schulenburg K; Scholz RP; Carpy A; Macek B; Remenyi A; Rajalingam K
EMBO J; 2014 Aug; 33(16):1784-801. PubMed ID: 24975362
[TBL] [Abstract][Full Text] [Related]
4. MEKK2 associates with the adapter protein Lad/RIBP and regulates the MEK5-BMK1/ERK5 pathway.
Sun W; Kesavan K; Schaefer BC; Garrington TP; Ware M; Johnson NL; Gelfand EW; Johnson GL
J Biol Chem; 2001 Feb; 276(7):5093-100. PubMed ID: 11073940
[TBL] [Abstract][Full Text] [Related]
5. PB1 domains of MEKK2 and MEKK3 interact with the MEK5 PB1 domain for activation of the ERK5 pathway.
Nakamura K; Johnson GL
J Biol Chem; 2003 Sep; 278(39):36989-92. PubMed ID: 12912994
[TBL] [Abstract][Full Text] [Related]
6. Activation of either ERK1/2 or ERK5 MAP kinase pathways can lead to disruption of the actin cytoskeleton.
Barros JC; Marshall CJ
J Cell Sci; 2005 Apr; 118(Pt 8):1663-71. PubMed ID: 15797923
[TBL] [Abstract][Full Text] [Related]
7. ERK5 activation is essential for osteoclast differentiation.
Amano S; Chang YT; Fukui Y
PLoS One; 2015; 10(4):e0125054. PubMed ID: 25885811
[TBL] [Abstract][Full Text] [Related]
8. Yap is a novel regulator of C2C12 myogenesis.
Watt KI; Judson R; Medlow P; Reid K; Kurth TB; Burniston JG; Ratkevicius A; De Bari C; Wackerhage H
Biochem Biophys Res Commun; 2010 Mar; 393(4):619-24. PubMed ID: 20153295
[TBL] [Abstract][Full Text] [Related]
9. MEK5 and ERK5 are localized in the nuclei of resting as well as stimulated cells, while MEKK2 translocates from the cytosol to the nucleus upon stimulation.
Raviv Z; Kalie E; Seger R
J Cell Sci; 2004 Apr; 117(Pt 9):1773-84. PubMed ID: 15075238
[TBL] [Abstract][Full Text] [Related]
10. Requirement of the MEK5-ERK5 pathway for neural differentiation in Xenopus embryonic development.
Nishimoto S; Kusakabe M; Nishida E
EMBO Rep; 2005 Nov; 6(11):1064-9. PubMed ID: 16179948
[TBL] [Abstract][Full Text] [Related]
11. The MEK5/ERK5 pathway mediates fluid shear stress promoted osteoblast differentiation.
Zhao LG; Chen SL; Teng YJ; An LP; Wang J; Ma JL; Xia YY
Connect Tissue Res; 2014 Apr; 55(2):96-102. PubMed ID: 24111522
[TBL] [Abstract][Full Text] [Related]
12. The MEK5/ERK5 mitogen-activated protein kinase cascade is an effector pathway of bone-sustaining bisphosphonates that regulates osteogenic differentiation and mineralization.
Adam C; Glück L; Ebert R; Goebeler M; Jakob F; Schmidt M
Bone; 2018 Jun; 111():49-58. PubMed ID: 29567200
[TBL] [Abstract][Full Text] [Related]
13. Common and Distinctive Functions of the Hippo Effectors Taz and Yap in Skeletal Muscle Stem Cell Function.
Sun C; De Mello V; Mohamed A; Ortuste Quiroga HP; Garcia-Munoz A; Al Bloshi A; Tremblay AM; von Kriegsheim A; Collie-Duguid E; Vargesson N; Matallanas D; Wackerhage H; Zammit PS
Stem Cells; 2017 Aug; 35(8):1958-1972. PubMed ID: 28589555
[TBL] [Abstract][Full Text] [Related]
14. PB1 domain-dependent signaling complex is required for extracellular signal-regulated kinase 5 activation.
Nakamura K; Uhlik MT; Johnson NL; Hahn KM; Johnson GL
Mol Cell Biol; 2006 Mar; 26(6):2065-79. PubMed ID: 16507987
[TBL] [Abstract][Full Text] [Related]
15. The MEK5-ERK5 Kinase Axis Controls Lipid Metabolism in Small-Cell Lung Cancer.
Cristea S; Coles GL; Hornburg D; Gershkovitz M; Arand J; Cao S; Sen T; Williamson SC; Kim JW; Drainas AP; He A; Cam LL; Byers LA; Snyder MP; Contrepois K; Sage J
Cancer Res; 2020 Mar; 80(6):1293-1303. PubMed ID: 31969375
[TBL] [Abstract][Full Text] [Related]
16. Proteomic analysis of tumor necrosis factor-alpha resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype.
Zhou C; Nitschke AM; Xiong W; Zhang Q; Tang Y; Bloch M; Elliott S; Zhu Y; Bazzone L; Yu D; Weldon CB; Schiff R; McLachlan JA; Beckman BS; Wiese TE; Nephew KP; Shan B; Burow ME; Wang G
Breast Cancer Res; 2008; 10(6):R105. PubMed ID: 19087274
[TBL] [Abstract][Full Text] [Related]
17. A novel mitogen-activated protein kinase docking site in the N terminus of MEK5alpha organizes the components of the extracellular signal-regulated kinase 5 signaling pathway.
Seyfried J; Wang X; Kharebava G; Tournier C
Mol Cell Biol; 2005 Nov; 25(22):9820-8. PubMed ID: 16260599
[TBL] [Abstract][Full Text] [Related]
18. Non-redundant function of the MEK5-ERK5 pathway in thymocyte apoptosis.
Sohn SJ; Lewis GM; Winoto A
EMBO J; 2008 Jul; 27(13):1896-906. PubMed ID: 18548009
[TBL] [Abstract][Full Text] [Related]
19. Insight into the binding properties of MEKK3 PB1 to MEK5 PB1 from its solution structure.
Hu Q; Shen W; Huang H; Liu J; Zhang J; Huang X; Wu J; Shi Y
Biochemistry; 2007 Nov; 46(47):13478-89. PubMed ID: 17985933
[TBL] [Abstract][Full Text] [Related]
20. The MEK5/ERK5 signalling pathway in cancer: a promising novel therapeutic target.
Simões AE; Rodrigues CM; Borralho PM
Drug Discov Today; 2016 Oct; 21(10):1654-1663. PubMed ID: 27320690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]